Pure Global

Electromyographic Calibration Guided by Depth of Anesthesia - Trial NCT04911088

Access comprehensive clinical trial information for NCT04911088 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospital Ulm and is currently Recruiting. The study focuses on Neuromuscular Blockade. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT04911088
Recruiting
Trial Details
ClinicalTrials.gov • NCT04911088
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Electromyographic Calibration Guided by Depth of Anesthesia
Does Calibration of Electromyography Guided by State Entropy Improve Measurement Precision

Study Focus

Neuromuscular Blockade

Observational

Sponsor & Location

University Hospital Ulm

Ulm, Germany

Timeline & Enrollment

N/A

Jan 16, 2022

Dec 01, 2022

60 participants

Primary Outcome

Tolerance interval of TOF ratios

Summary

The goal of the CELESTE study is to evaluate whether calibration of EMG is needed for
 reliable interpretation of neuromuscular function and if so, to identify the minimal
 necessary depth of anesthesia.

ICD-10 Classifications

Skeletal muscle relaxants [neuromuscular blocking agents]
Poisoning: Skeletal muscle relaxants [neuromuscular blocking agents]
Other neuromuscular dysfunction of bladder
Neuromuscular dysfunction of bladder, unspecified
Neuromuscular scoliosis

Data Source

ClinicalTrials.gov

NCT04911088

Non-Device Trial